Common use of EX-PROGRAM PRODUCTS Clause in Contracts

EX-PROGRAM PRODUCTS. Subject to the terms and conditions of this Agreement and any applicable [**], and on a Scientifically-Qualified Target-by-Scientifically-Qualified Target basis, Millennium hereby grants to Aventis a worldwide, non-exclusive, non-royalty-bearing license, under Millennium's Patent Rights (excluding the Millennium Research Program Chemistry Intellectual Property), to use Scientifically-Qualified Targets to identify, evaluate and optimize Small Molecules for use [**]; PROVIDED, HOWEVER, that with respect to each Scientifically-Qualified Target, such license shall be limited to (i) know-how disclosed to Aventis prior to the date such target is designated a Scientifically-Qualified Target, (ii) Patent Rights which exist as of the date such target is designated a Scientifically-Qualified Target, and (iii) any claim of a patent which (A) claims priority from a patent application within Patent Rights which exists as of the date such target is designated an Scientifically-Qualified Target and (B) is adequately supported in such application from which it claims priority to satisfy the requirements of 35 U.S.C. 112. Such license shall further include the right to grant sublicenses to Affiliates of Aventis and to Third Parties in accordance with the terms set forth in Section 7.2.5.

EX-PROGRAM PRODUCTS. Subject to the terms and conditions of this Agreement and any applicable [**]Burdened Technology Obligations, and on a Scientifically-Qualified Target-by-Scientifically-Qualified Target basis, Millennium Aventis hereby grants to Aventis Millennium a worldwide, non-exclusive, non-royalty-bearing license, license under Millennium's Patent Rights Aventis' rights to the Program Intellectual Property (excluding the Millennium Aventis Research Program Chemistry Intellectual Property), to use Scientifically-Qualified Targets to identify, evaluate and optimize Small Molecules for use [**]; PROVIDED, HOWEVER, that with respect to each Scientifically-Scientifically- Qualified Target, such license shall be limited to (i) know-how disclosed to Aventis Millennium prior to the date such target is designated a Scientifically-Scientifically- Qualified Target, (ii) Patent Rights which exist as of the date such target is designated a Scientifically-Qualified Target, and (iii) any claim of a patent which (A) claims priority from a patent application within Patent Rights which exists as of the date such target is designated an a Scientifically-Qualified Target and (B) is adequately supported in such application from from, which it claims priority to satisfy the requirements of 35 U.S.C. 112. Such license shall further include the right to grant sublicenses to Affiliates of Aventis Millennium and to Third Parties in accordance with the terms set forth in Section 7.2.5.

EX-PROGRAM PRODUCTS. Subject to the terms and conditions of this Agreement and any applicable [**]Burdened Technology Obligations, and on a Scientifically-Qualified Targetcompound-by-Scientifically-Qualified Target compound basis, Millennium Aventis hereby grants to Aventis Millennium a worldwide, non-exclusive, non-royalty-bearing license, under Millennium's Patent Rights Aventis' rights to the Program Intellectual Property (excluding the Millennium Aventis Research Program Chemistry Intellectual Property), to use Scientifically-Qualified Targets to identify, evaluate and optimize Small Molecules for use Develop Ex-Program Products [**]; PROVIDED, HOWEVER, that with respect to each Scientifically-Qualified Target, such license shall be limited to (i) know-how disclosed to Aventis Millennium prior to the date such target is designated a Scientifically-Qualified Target, (ii) Patent Rights which exist as of the date such target is designated a Scientifically-Qualified Target, and (iii) any claim of a patent which (A) claims priority from a patent application within Patent Rights which exists as of the date such target is designated an a Scientifically-Qualified Target and (B) is adequately supported in such application from which it claims priority to satisfy the requirements of 35 U.S.C. 112. Such license shall further include the right to grant sublicenses to Affiliates of Aventis Millennium and to Third Parties in accordance with the terms set forth in Section 7.2.5.

EX-PROGRAM PRODUCTS. Subject to the terms and conditions of this Agreement and any applicable [**]Burdened Technology Obligations, and on a Scientifically-Qualified Targetcompound-by-Scientifically-Qualified Target compound basis, Millennium hereby grants to Aventis a worldwide, non-exclusive, non-royalty-bearing license, under Millennium's Patent Rights rights to the Program Intellectual Property (excluding the Millennium Research Program Chemistry Intellectual Property), to use Scientifically-Qualified Targets to identify, evaluate and optimize Small Molecules for use Develop Ex-Program Products [**]; PROVIDED, HOWEVER, that that, with respect to each Scientifically-Qualified Target, such license shall be limited to (i) know-how disclosed to Aventis prior to the date such target is designated a Scientifically-Qualified Target, (ii) Patent Rights which exist as of the date such target is designated a Scientifically-Qualified Target, and (iii) any claim of a patent which (A) claims priority from a patent application within Patent Rights which exists as of the date such target is designated an a Scientifically-Qualified Target and (B) is adequately supported in such application from from, which it claims priority to satisfy the requirements of 35 U.S.C. 112. Such license shall further include the right to grant sublicenses to Affiliates of Aventis and to Third Parties in accordance with the terms set forth in Section 7.2.5.